MedDRA-Based Pharmacovigilance & Drug Safety Annotation

The provider provides expert-led pharmacovigilance annotation by structuring adverse drug reactions (ADRs), side effects, patient complaints, medication responses, and safety signals using MedDRA’s hierarchical terminology. Each annotation captures clinical relationships between drugs, symptoms, diagnoses, and outcomes, producing high-quality, regulatory-ready safety datasets. These MedDRA-mapped datasets support pharmacovigilance reporting, post-market surveillance, benefit–risk assessment, and automated safety analytics. AI teams use the data to train and validate models for adverse event detection, safety signal identification, and trend monitoring across unstructured sources such as telemedicine transcripts, clinical notes, and patient portals. All annotations are reviewed by qualified medical professionals to ensure accurate differentiation between drug-related effects and unrelated findings, making the datasets suitable for regulated pharmaceutical and life sciences environments.